
C4X Discovery Holdings inks $402m deal with AstraZeneca
Under the agrrement, C4X Discovery Holdings plc (C4XD) will receive pre-clinical milestone payments worth up to $16m ahead of the first clinical...

Cultimate Foods UG raises €700.000 in pre-seed financing
Berlin food-tech specialist Cultimate Foods UG has raised €700.000 in a pre-seed round led by Big Idea Ventures LLC, ProVeg International e.V. and...

CatalYm GmbH raises €50m to push visugromab development
Following a €60m Series B financing in 2020, Martinsried-based CatalYm GmbH announced the closing of a Series C financing round of €50m. The...

Amsterdam Neogene Therapeutics aquired by AstraZeneca
Neogene Therapeutics is developing both patient-specific and shared neoantigen TCR programmes to deliver such TCRs into a patient's own T cells and...

ExeVir receives EIB risk finance for multiple COVID-19 nanobody
With the resurgence of COVID-19 in China, ExeVir BIO sees commercial potential in the future treatment of immunocompromised people, who make up 3%...

EU Health Union ignoring cardiology
While the EU has already presented rules to establish a European Health Data Space (EHDS) and Europe’s Plan against Cancer within its Medicines...

New partnerships push InDevR for Series B financing
Investments into InDevR, Inc. came from New York-based Adjuvant Capital ($4m) and French bioMèrieux SA ($5m), which will enable the commercial...